🧾 What This Document Is

This is an 8-K filing, which is a report companies file with the SEC to announce major, shareholder-affecting news. This specific announcement, labeled as Exhibit 99.1, reveals that SRx Health Solutions has made a significant new investment in a fund focused on Artificial Intelligence and space technology. It’s a window into a major strategic move by the company.

🏢 What The Company Does

👉 In simple terms, SRx Health Solutions (ticker: SRXH) is a healthcare company. However, this filing shows it's in the middle of a major transformation. It has a pending merger agreement with EMJ Crypto Technologies (EMJX), which is described as a "digital-asset treasury operating platform." This means the company is pivoting from traditional healthcare toward the world of digital assets and, now, frontier tech investments.

💰 The Investment: AI & Space

The core news is a major financial bet. SRx Health, alongside its future merger partner EMJX, has invested greater than 10% of its investable capital into "Astro Investment XVII."

• What is it? This is a Special Purpose Vehicle (SPV) set up by Astro Capital. An SPV is a separate legal entity created to pool money for a specific, isolated investment.
• The Thesis: The investment is focused on the convergence of Artificial Intelligence (“AI”) and space. This is a high-risk, high-growth area targeting technologies like satellite data analytics, AI for space operations, and space-based manufacturing.

👉 Why it matters: This isn't a small side bet. Committing over 10% of available capital signals this is a major strategic pillar for the combined company post-merger. They are betting their future on very futuristic sectors.

🤝 The Pending Merger Context

This investment is announced jointly with EMJ Crypto Technologies, the company SRx Health is already set to merge with. Eric M. Jackson, the founder and CEO of EMJX, is quoted calling the investment a belief in "long-term value." 👉 Key Insight: This shows the strategic direction for the combined entity is being shaped now. The new leadership (from EMJX) is already directing capital, indicating the post-merger company will likely have a heavy focus on digital assets and technology venture investing.

📅 Key Dates & Documents

The filing reminds investors that the proposed merger is still pending. Full details about the transaction will be in future SEC filings.

• Key documents like the Registration Statement and Information Statement/Prospectus will be available for free at the SEC's website (www.sec.gov) once they are filed.
• The company's own website information is not part of this official communication.

👉 What to do: Interested investors should watch the SEC website for these upcoming documents to understand the full merger terms and risks.

👥 Contact Information

For investor questions about this news: Company Contact: Kent Cunningham, Chief Executive Officer

Investor Relations Firm: KCSA Strategic Communications Valter Pinto, Managing Director Phone: 212-896-1254 Email: [email protected]

🧠 The Analogy

This is like a small-town pharmacy (SRx Health) announcing it’s merging with a cryptocurrency startup (EMJX), and before the ink is dry on that deal, they’re taking a huge chunk of the cash register to buy a stake in a rocket science and supercomputer fund (Astro Capital). It’s a dramatic and sudden change of business direction.

🧩 Final Takeaway

SRx Health Solutions is using a pending merger as a springboard to radically change its business model. This 10%+ investment in AI and space tech through Astro Capital signals that the future company intends to be a venture-style investor in cutting-edge, speculative technologies, a far cry from its original healthcare focus.